Members only Finance Featured Wall Street Is Buying Phase 1 Again A food-allergy biotech with one cohort of human data just closed a $365 million IPO and trades near a $1.5 billion valuation. Biotech's IPO class of 2026 says the window is wide open. The aftermarket scoreboard says mind which side of it you're standing on.
Markets Featured $CLS: Celestica Guides to 90% Growth in 2027 and the Market Is Paying 13x for It. Here's the Catch Celestica beat Q3 on every line, revenue up 83%, and guided 2027 to $40 billion. The stock popped 11% premarket yet trades at 12.7x the new guide. The three-customer concentration math, the free cash flow cut, the $310 equity raise signal, and the scenario zones.
Markets Featured $PBR: The Market Priced In a Bolsonaro Win. Lula's Fourth Term Erased $34 Billion Before the Open Petrobras ADRs are down 21% premarket after Lula's shock runoff win. The dividend formula, the fuel-price gap at $110 Brent, the November 10 date, and the scenario zones.
Paid-members only Markets Featured Top 10 Stocks We're Watching This Week — Decision Week Edition A Fed hold Wednesday with Microsoft hours later, Brent at six-month highs on the worst Hormuz month of the war, and eight of our ten reporting earnings this week. Ten names for decision week, all tracked on the Watchlist from these prices.
Members only Finance Featured Private Credit Isn't Defaulting. It's Deferring. Moody's counts a 4% default rate in US private credit — until it counts the borrowers paying interest with more debt. Then it's 5.8%. Inside the deferral economy, and what the BDC tape is pricing next.
Members only Energy Featured Why Is America Importing Russian Diesel? A Russian tanker is steaming toward a US port, Washington is lending out a third of its emergency heating oil reserve, and retail diesel is above $6 a gallon. The crisis isn't crude — it's refining. Here's what that distinction is worth.
Geopolitics Featured Washington Just Moved to Wall Off Chinese Biotech. Big Pharma Got a Door. Treasury's proposed COINS Act rules would bar U.S. equity investment across broad swaths of Chinese biotech -- while sparing pharma's record-setting cash licensing deals. What's banned, what's exempt, and what it means for the industry.
Paid-members only Markets Featured $MRNA: Up 6x This Year, Down 18% on Good News. What the Leaked Cancer Vaccine Data Actually Says Moderna fell 17.6% after its Phase 3 melanoma vaccine data leaked early: a 42% recurrence-risk reduction against a 49% anchor the market had priced for. The trial-design detail the sellers skipped, the 50/50 Merck math, and the scenario zones into Saturday's ESMO presentation.
Members only Markets Featured Nobody Canceled Netflix. They Just Stopped Watching. Netflix beat earnings, grew revenue 12%, and bought back a record $4.8 billion of stock — then fell to a two-year low. The market isn't pricing the quarter. It's pricing the hours.
Paid-members only Markets Featured The Private Key Was the Number 4 Eight secret keys guarding the web were small enough to guess by hand — one was 4. Five days later, eMudhra has lost a third of its market value and its global TLS business. The company calls it 1% of revenue. The market is pricing something much bigger.
Macro Featured The Layoffs Are at Four-Year Lows. AI Just Became the Top Reason for Them. U.S. layoffs are at a four-year low, hiring is the weakest since 2011 — and AI just became the most-cited reason American employers give for cutting jobs. Barclays' 5,000-job cut shows how the new workforce math works.
Paid-members only Markets Featured $CRWV: The Bonds Yield 15%, Goldman Says Buy. Inside CoreWeave's $35 Billion Debt Stack CoreWeave's stock is down 56% while its order book hit $104 billion. The bond market just repriced the company's debt to distress levels and Goldman upgraded into it. The numbers on both sides of that argument, itemized.
Paid-members only Geopolitics Featured Who Gets Paid When Venezuela Reopens? Maduro is awaiting trial in New York, Washington owns 35% of a Barbados-registered oil venture, and more than $100 billion in defaulted claims is lining up behind every new barrel. The queue — not the oil — is the trade.
Members only Energy Featured Oil Found a Way Around the Strait. Helium Didn't. Qatar's helium — a third of world supply — has been locked behind the Strait of Hormuz since March, and the industry now concedes it won't return before 2027. The winners aren't the stocks you'd expect.
Markets Featured Boeing's Biggest 737 Is Finally Cleared to Fly. The Hard Part Starts Now. Nine years after its Paris Air Show debut, the FAA certified Boeing's 737 MAX 10 — a plane carrying 1,555 unfilled orders and nearly a third of the entire MAX backlog. Certification was the milestone. Delivering is the business.
Paid-members only Markets Featured $BRZE: Salesforce Will Pay $47.50 in Cash. The Market Says $45.57. Here Is What the Gap Is Pricing Salesforce is buying Braze for $47.50 a share in cash, a 58% premium. The stock closed at $45.57. That 4.2% spread is a live market price on regulatory risk, timeline, and deal-break odds. We decompose all three.
Members only Defence Featured Drones Broke the Economics of Air Defense. The Pentagon's Fix Costs $32,000. The Pentagon just committed to up to 25,000 of BAE's $32,000 APKWS drone-killer kits a year for seven years. BAE holds a record £84 billion backlog and trades 16% below its March peak. The math behind both numbers.
Members only Infrastructure Featured The Colorado River Deal Died. The Lawsuits Have Started. Seven states had four years to agree on sharing a shrinking Colorado River. Washington wrote the rules itself — and Nevada and Arizona are now suing over cuts of up to 3.6 million acre-feet. Who absorbs them, and which assets are repricing already.
Paid-members only Markets Featured $IRON: The Drug Roche Threw Away Just Swept Phase 3, and the FDA Clock Restarts in December Disc Medicine jumped 38.9% after bitopertin hit every APOLLO endpoint, eight months after an FDA rejection. The resubmission math, the $350M raise, and the scenario zones.
Macro Featured New York Is Losing Restaurants Faster Than It Did in the Pandemic BLS data shows New York lost 1,928 restaurants in a year — a steeper decline than any quarter of the pandemic. No lockdown required: the cost math stopped working, and it isn't unique to New York.
Members only Space Economy Featured Starlink Broke the Carrier Cartel. Europe Is Building One Back. Deutsche Telekom, Orange, Telefónica, and Vodafone just signed a pact to bid jointly for Europe's 2 GHz satellite spectrum — two weeks after the FCC cleared SpaceX's 15,000-satellite Starlink Mobile constellation. The satellite-to-phone land grab is now a two-continent war.
Members only Markets Featured The Biggest IPO in African History Is Being Sold by Text Message Dangote's $1.6 billion refinery IPO was covered within hours — yet it's staying open until October 27. The real project isn't the raise: it's building the rails for ten million shareholders across 51 countries.
Macro Featured Mortgage Rates Hit 7.4%. Half the Housing Market Didn't Notice. Cash buyers are transacting through three-year-high mortgage rates while first-time buyers fall to a record-low 21% of the market. Inside America's K-shaped housing economy — and why it matters two weeks before the midterms.
Paid-members only Markets Featured $SAFX: The Merger Closed, the Stock Fell 62% in Three Weeks, and the Nasdaq Clock Runs Out December 7 XCF Global closed its three-party merger and the stock fell anyway. The real story: a ~598 million share count, $329,084 of cash against a $137 million defaulted loan, a reverse-split vote, and a December 7 Nasdaq deadline.
Members only Markets Featured Wall Street Was Closed. The Margin Calls Weren't. On Saturday night, $52 million in leveraged chip-stock bets were liquidated in ten minutes — while the stocks themselves sat frozen at Friday's close. Crypto built a 24/7 shadow stock market. This weekend it traded against itself.